148 related articles for article (PubMed ID: 3570896)
21. Mechanism of radiosensitization by halogenated pyrimidines: effect of BrdU on radiation induction of DNA and chromosome damage and its correlation with cell killing.
Iliakis G; Kurtzman S; Pantelias G; Okayasu R
Radiat Res; 1989 Aug; 119(2):286-304. PubMed ID: 2756119
[TBL] [Abstract][Full Text] [Related]
22. BrdUrd-induced radiosensitization of two human tumour cell lines at iso-levels of incorporation.
Franken NA; Van Bree C; Kipp JB; Rodermond HM; Haveman J; Barendsen GW
Oncol Rep; 2000; 7(5):937-40. PubMed ID: 10948317
[TBL] [Abstract][Full Text] [Related]
23. The dependence of halogenated pyrimidine incorporation and radiosensitization on the duration of drug exposure.
Lawrence TS; Davis MA; Maybaum J; Stetson PL; Ensminger WD
Int J Radiat Oncol Biol Phys; 1990 Jun; 18(6):1393-8. PubMed ID: 2370189
[TBL] [Abstract][Full Text] [Related]
24. Modulation of IdUrd-DNA incorporation and radiosensitization in human bladder carcinoma cells.
Kunugi KA; Vazquez-Padua MA; Miller EM; Kinsella TJ
Cancer Res; 1990 Aug; 50(16):4962-7. PubMed ID: 2199032
[TBL] [Abstract][Full Text] [Related]
25. The mismatch repair protein, hMLH1, mediates 5-substituted halogenated thymidine analogue cytotoxicity, DNA incorporation, and radiosensitization in human colon cancer cells.
Berry SE; Garces C; Hwang HS; Kunugi K; Meyers M; Davis TW; Boothman DA; Kinsella TJ
Cancer Res; 1999 Apr; 59(8):1840-5. PubMed ID: 10213489
[TBL] [Abstract][Full Text] [Related]
26. Mechanism of radiosensitization by halogenated pyrimidines: effect of BrdU on cell killing and interphase chromosome breakage in radiation-sensitive cells.
Iliakis G; Pantelias G; Kurtzman S
Radiat Res; 1991 Jan; 125(1):56-64. PubMed ID: 1986401
[TBL] [Abstract][Full Text] [Related]
27. Comparison of the bromodeoxyuridine-mediated sensitization effects between low-LET and high-LET ionizing radiation on DNA double-strand breaks.
Fujii Y; Genet MD; Roybal EJ; Kubota N; Okayasu R; Miyagawa K; Fujimori A; Kato TA
Oncol Rep; 2013 Jun; 29(6):2133-9. PubMed ID: 23525528
[TBL] [Abstract][Full Text] [Related]
28. Mutual kinetic interaction between 5-fluorouracil and bromodeoxyuridine or iododeoxyuridine in dogs.
Smith DE; Brenner DE; Knutsen CA; Deremer SJ; Terrio PA; Johnson NJ; Stetson PL; Ensminger WD
Drug Metab Dispos; 1993; 21(2):277-83. PubMed ID: 8097697
[TBL] [Abstract][Full Text] [Related]
29. Effects of bleomycin with iododeoxyuridine, 5'-amino-5'-deoxythymidine, and radiation in a human bladder cancer cell line.
Kunugi KA; Lindstrom MJ; Kinsella TJ
Radiat Res; 1993 Aug; 135(2):262-8. PubMed ID: 7690149
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of incorporated iododeoxyuridine cellular radiosensitization by photon activation therapy.
Miller RW; DeGraff W; Kinsella TJ; Mitchell JB
Int J Radiat Oncol Biol Phys; 1987 Aug; 13(8):1193-7. PubMed ID: 3610707
[TBL] [Abstract][Full Text] [Related]
31. Fluorodeoxyuridine-mediated modulation of iododeoxyuridine incorporation and radiosensitization in human colon cancer cells in vitro and in vivo.
Lawrence TS; Davis MA; McKeever PE; Maybaum J; Stetson PL; Normolle DP; Ensminger WD
Cancer Res; 1991 Aug; 51(15):3900-5. PubMed ID: 1830239
[TBL] [Abstract][Full Text] [Related]
32. The use of halogenated thymidine analogs as clinical radiosensitizers: rationale, current status, and future prospects: non-hypoxic cell sensitizers.
Kinsella TJ; Mitchell JB; Russo A; Morstyn G; Glatstein E
Int J Radiat Oncol Biol Phys; 1984 Aug; 10(8):1399-406. PubMed ID: 6381432
[TBL] [Abstract][Full Text] [Related]
33. Comparative utilization of bromodeoxyuridine and iododeoxyuridine triphosphates for mammalian DNA replication in vitro.
Gautschi JR; Burkhalter M; Baumann EA
Biochim Biophys Acta; 1978 Mar; 518(1):31-6. PubMed ID: 629978
[TBL] [Abstract][Full Text] [Related]
34. Interaction of iododeoxyuridine and its primary metabolite, iodouracil on radiation response.
Kinsella TJ; Dobson PP; Mitchell JB
Int J Radiat Oncol Biol Phys; 1986 Aug; 12(8):1519-22. PubMed ID: 3759574
[TBL] [Abstract][Full Text] [Related]
35. Hyperthermia and incorporation of halogenated pyrimidines: radiosensitization in cultured rodent and human tumor cells.
Van Bree C; Franken NA; Bakker PJ; Klomp-Tukker LJ; Barendsen GW; Kipp JB
Int J Radiat Oncol Biol Phys; 1997 Sep; 39(2):489-96. PubMed ID: 9308955
[TBL] [Abstract][Full Text] [Related]
36. Mechanism of radiosensitization by halogenated pyrimidines: bromodeoxyuridine and beta-arabinofuranosyladenine affect similar subsets of radiation-induced potentially lethal lesions in plateau-phase Chinese hamster ovary cells.
Iliakis G; Kurtzman S
Radiat Res; 1991 Jul; 127(1):45-51. PubMed ID: 2068271
[TBL] [Abstract][Full Text] [Related]
37. Radiobiology and clinical application of halogenated pyrimidine radiosensitizers.
Mitchell JB; Russo A; Cook JA; Straus KL; Glatstein E
Int J Radiat Biol; 1989 Nov; 56(5):827-36. PubMed ID: 2573682
[TBL] [Abstract][Full Text] [Related]
38. Measurement of thymidine replacement in patients with high grade gliomas, head and neck tumors, and high grade sarcomas after continuous intravenous infusions of 5-iododeoxyuridine.
Cook JA; Glass J; Lebovics R; Bobo H; Pass H; DeLaney TF; Oldfield EH; Mitchell JB; Glatstein E; Goffman TE
Cancer Res; 1992 Feb; 52(3):719-25. PubMed ID: 1732059
[TBL] [Abstract][Full Text] [Related]
39. Fixation of radiation-induced potentially lethal damage by anisotonic treatment and its modification by DMSO or BrdUrd in V79 cells.
Raaphorst GP; Azzam EI
Radiat Environ Biophys; 1985; 24(3):175-84. PubMed ID: 4034923
[TBL] [Abstract][Full Text] [Related]
40. The interaction of hydroxyurea and iododeoxyuridine on the radiosensitivity of human bladder cancer cells.
Kuo ML; Kunugi KA; Lindstrom MJ; Kinsella TJ
Cancer Res; 1995 Jul; 55(13):2800-5. PubMed ID: 7796406
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
